Abstract:
A rock drill system may include a support arrangement including a feed channel, a rock drill assembly movably associated with the feed channel, and a fluid conductor having a first end connected to the rock drill assembly and a second end associated with the support arrangement. The system may further include a tensioning arm pivotally coupled to the support arrangement, wherein the tensioning arm is engageable with the fluid conductor to tension the fluid conductor.
Abstract:
The invention is directed to compounds according to formula (I): where R 1 is L 1 C(O)OT or L 1 C(O)OL 2 C(O)OT; R 2 is a substituted or unsubstituted C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 2 -C 10 alkynyl, or R 1 ; n is an integer from 0 to 5; each R 3 is independently halogen or R 2 ; R 4 and R 5 are independently H, halogen, CN or CF 3 ; L 1 and L 2 are each independently a bond, a substituted or unsubstituted C 1 -C 10 alkylene, C 2 -C 10 alkenylene, or C 2 -C 10 alkynylene; and T is H, a substituted or unsubstituted C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 2 -C 10 alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition.
Abstract:
The invention is directed to compounds according to formula (I): where R1 is L1C(O)OT or L1C(O)OL2C(O)OT; R2 is a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, or R1; n is an integer from 0 to 5; each R3 is independently halogen or R2; L1 and L2 are each independently a bond, a substituted or unsubstituted C1-C10 alkylene, C2-C10 alkenylene, or C2-C10 alkynylene; and T is H, a substituted or unsubstituted C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl, nitrophenol, or cyclopropyl. The invention is also directed to a pharmaceutical composition comprising a compound according to formula (I) and a pharmaceutically acceptable carrier, and to methods for providing anesthesia in mammals by administering such a pharmaceutical composition.
Abstract:
A flexible optical marker is applied to an optical scale substrate to make an optical scale assembly for an optical position encoder. The marker may be a limit marker, index marker, or other type of marker. The marker substrate may be a plastic film such as polyester, having a microstructured pattern on one surface covered with a reflective metal coating, and an adhesive layer for affixing to the optical scale substrate. The marker may be applied with a handle portion that is separated from the marker after the marker is affixed. The marker may be especially useful with a flexible scale substrate such as a metal tape substrate. By affixing the marker to the scale substrate as a separate step of making an encoder scale, various benefits such as reduced inventory, cost, and lead time may be achieved.
Abstract:
A remote application server that operates cooperatively with an embedded radio receiver (52) in a vehicle can include a standalone portable device (12 or 60) having memory (41) for storing and independently presenting audio or data wirelessly received by the embedded receiver and a communication interface (45) in the standalone portable device for receiving audio and data received at the embedded receiver and for transferring audio or data or both to and from a computer network (49) when coupled to the network and for uploading stored audio or data or both to a user interface (57) when coupled to the embedded receiver. The server can include a processor (46) in the standalone portable device for remotely running applications on the standalone portable device that are presented on the user interface coupled to the embedded receiver via a thin client (71) resident in the user interface or embedded receiver.
Abstract:
Neurite outgrowth-promoting prostaglandins (NEPPs) and other electrophilic compounds bind to Keapl, a negative regulator of the transcription factor Nrf2, and prevent Keapl -mediated inactivation of Nrf2 and, thus, enhance Nrf2 translocation into the nucleus of neuronal cells. Therefore, neuroprotective compositions and related methods are provided that employ such neuroprotective compounds, and prodrugs of such compounds, to cause dissociation of Nrf2 from a Keapl /Nrf2 complex.
Abstract:
A combustor liner assembly (46) includes a liner assembly (56), including a hot dome (82), a hot wall (78, 80), and an impingement shield (76, 96). The liner assembly further includes a convector assembly (58). The combustor liner assembly further includes an impingement dome assembly (60), including a ring-shaped portion (104) defining a plurality of apertures (106) configured to receive a plurality of fuel injectors, and a face (126). The ring- shaped portion and the face define an annular passage (128), and the face defines a plurality of apertures and a plurality of orifices (130). The convector assembly and the impingement dome assembly are operably coupled to one another, and the plurality of orifices of the face are configured such that the hot dome is exposed to air flowing in the annular passage of the impingement dome assembly. The combustor liner assembly is configured to provide flow communication between the annular passage of the impingement dome assembly and the plurality of fuel injectors.
Abstract:
An integrated circuit (IC) chip having repeaters for propagating signals along relatively long wires that extend between and among lower-level physical blocks of the IC chip, wherein the repeaters are implemented as clocked flip-flops (or "repeater flops"). A method for automatically inserting and allocating such repeater flops during the logical and physical design of the IC chip is also provided.
Abstract:
An integrated circuit (IC) chip having repeaters for propagating signals along relatively long wires that extend between and among lower-level physical blocks of the IC chip, wherein the repeaters are implemented as clocked flip-flops (or "repeater flops"). A method for automatically inserting and allocating such repeater flops during the logical and physical design of the IC chip is also provided.
Abstract:
This invention concerns compositions for the treatment of urinary frequency, urinary urgency and urinary incontinence comprising a selected antagonist of the NK-1 receptor or a pharmaceutically acceptable salt thereof and an anti-muscarinic agent or a pharmaceutically acceptable salt thereof. This invention concerns combination therapy for urinary frequency, urinary urgency and urinary incontinence wherein one of the active agents is a selected antagonist of the NK-1 receptor or a pharmaceutically acceptable salt thereof and another is an anti-muscarinic agent or a pharmaceutically acceptable salt thereof.